C
CSTL icon

Covestor’s Castle Biosciences CSTL Stock Holding History

Covestor’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Sell
473
-623
-57% -$13.9K 0.01% 1499
2026
Q1 		$27K Buy
1,096
+98
+10% +$3.21K 0.02% 996
2025
Q4 		$39K Sell
998
-1,071
-52% -$34.5K 0.02% 998
2025
Q3 		$47K Sell
2,069
-311
-13% -$6.32K 0.03% 934
2025
Q2 		$49K Buy
2,380
+1,161
+95% +$21.5K 0.03% 893
2025
Q1 		$24K Buy
1,219
+283
+30% +$7.01K 0.02% 1129
2024
Q4 		$25K Buy
+936
New +$28.5K 0.02% 1109
2022
Q1 		– Sell
-7
Closed – – 2158
2021
Q4 		$0 Buy
+7
New +$366 ﹤0.01% 2143

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Covestor's CSTL Position: Q2 2026 in Review

Covestor reduced its Castle Biosciences (CSTL) stake by 57% in Q2 2026, selling an estimated $13.9K and leaving 473 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #1499.

Covestor first reported a position in CSTL in Q4 2021 and has held it in 8 quarters since. The position peaked at $49K in Q2 2025. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Covestor held 473 shares of Castle Biosciences worth $11K as of Q2 2026.
  • Covestor sold 623 Castle Biosciences shares in Q2 2026, an estimated $13.9K.
  • Castle Biosciences made up 0.01% of Covestor's portfolio in Q2 2026, its #1499 holding.
  • Covestor first reported a position in Castle Biosciences in Q4 2021 and has held it in 8 quarters since.
  • Covestor's Castle Biosciences position peaked at $49K in Q2 2025.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.